-
1
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma ina randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma ina randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
-
(2009)
Lancet Oncol.
, vol.10
, Issue.5
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
2
-
-
79957905986
-
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
-
Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: Seeing order in the chaos. Glia. 2011;59(8):1190-1199.
-
(2011)
Glia
, vol.59
, Issue.8
, pp. 1190-1199
-
-
Huse, J.T.1
Phillips, H.S.2
Brennan, C.W.3
-
3
-
-
78650371145
-
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses
-
Kong LY, Wu AS, Doucette T, et al. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res. 2010;16(23): 5722-5733.
-
(2010)
Clin Cancer Res.
, vol.16
, Issue.23
, pp. 5722-5733
-
-
Kong, L.Y.1
Wu, A.S.2
Doucette, T.3
-
4
-
-
84867504682
-
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
-
Doucette TA, Kong LY, Yang Y, et al. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012;14(9):1136-1145.
-
(2012)
Neuro Oncol.
, vol.14
, Issue.9
, pp. 1136-1145
-
-
Doucette, T.A.1
Kong, L.Y.2
Yang, Y.3
-
5
-
-
84886698315
-
Innate and adaptive immune cells in the tumor microenvironment
-
Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014-1022.
-
(2013)
Nat Immunol.
, vol.14
, Issue.10
, pp. 1014-1022
-
-
Gajewski, T.F.1
Schreiber, H.2
Fu, Y.X.3
-
6
-
-
84884252997
-
Myeloid-derived suppressor cells in cancer: Recent progress and prospects
-
Khaled YS, Ammori BJ, Elkord E. Myeloid-derived suppressor cells in cancer: Recent progress and prospects. Immunol Cell Biol. 2013;91(8):493-502.
-
(2013)
Immunol Cell Biol.
, vol.91
, Issue.8
, pp. 493-502
-
-
Khaled, Y.S.1
Ammori, B.J.2
Elkord, E.3
-
7
-
-
39649098678
-
Tumour immunity: Effector response to tumour and role of the microenvironment
-
Mantovani A, Romero P, Palucka AK, et al. Tumour immunity: Effector response to tumour and role of the microenvironment. Lancet. 2008;371(9614): 771-783.
-
(2008)
Lancet.
, vol.371
, Issue.9614
, pp. 771-783
-
-
Mantovani, A.1
Romero, P.2
Palucka, A.K.3
-
8
-
-
84893770485
-
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
-
Sarkar S, Doring A, Zemp FJ, et al. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nat Neurosci. 2014; 17(1):46-55.
-
(2014)
Nat Neurosci.
, vol.17
, Issue.1
, pp. 46-55
-
-
Sarkar, S.1
Doring, A.2
Zemp, F.J.3
-
9
-
-
84962269800
-
Immunosuppressive mechanisms in glioblastoma
-
Nduom EK, Weller M, Heimberger AB. Immunosuppressive mechanisms in glioblastoma. Neuro Oncol. 2015;17(SUPPL. 7):vii9-vii14.
-
(2015)
Neuro Oncol.
, vol.17
, pp. vii9-vii14
-
-
Nduom, E.K.1
Weller, M.2
Heimberger, A.B.3
-
10
-
-
84985941767
-
Immune evasion strategies of glioblastoma
-
Razavi SM, Lee KE, Jin BE, et al. Immune evasion strategies of glioblastoma. Front Surg. 2016;3:11.
-
(2016)
Front Surg.
, vol.3
, pp. 11
-
-
Razavi, S.M.1
Lee, K.E.2
Jin, B.E.3
-
11
-
-
84935143364
-
Immunosuppressive mechanisms of malignant gliomas: Parallels at non-CNS sites
-
Perng P, Lim M. Immunosuppressive mechanisms of malignant gliomas: Parallels at non-CNS sites. Front Oncol. 2015;5:153.
-
(2015)
Front Oncol.
, vol.5
, pp. 153
-
-
Perng, P.1
Lim, M.2
-
12
-
-
84897527381
-
Immune heterogeneity of glioblastoma subtypes: Extrapolation from the cancer genome atlas
-
Doucette T, Rao G, Rao A, et al. Immune heterogeneity of glioblastoma subtypes: Extrapolation from the cancer genome atlas. Cancer Immunol Res. 2013; 1(2):112-122.
-
(2013)
Cancer Immunol Res.
, vol.1
, Issue.2
, pp. 112-122
-
-
Doucette, T.1
Rao, G.2
Rao, A.3
-
13
-
-
84880062228
-
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma
-
Wei J, Wang F, Kong LY, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013;73(13): 3913-3926.
-
(2013)
Cancer Res.
, vol.73
, Issue.13
, pp. 3913-3926
-
-
Wei, J.1
Wang, F.2
Kong, L.Y.3
-
14
-
-
84904856334
-
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma
-
Xu S, Wei J, Wang F, et al. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014; 106(8):dju162.
-
(2014)
J Natl Cancer Inst.
, vol.106
, Issue.8
, pp. dju162
-
-
Xu, S.1
Wei, J.2
Wang, F.3
-
15
-
-
84964314436
-
Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy
-
Schrand B, Berezhnoy A, Brenneman R, et al. Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy. Cancer Immunol Res. 2014;2(9): 867-877.
-
(2014)
Cancer Immunol Res.
, vol.2
, Issue.9
, pp. 867-877
-
-
Schrand, B.1
Berezhnoy, A.2
Brenneman, R.3
-
16
-
-
33847220736
-
Genome-wide analysis of foxp3 target genes in developing and mature regulatory T cells
-
Zheng Y, Josefowicz SZ, Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature. 2007;445(7130): 936-940.
-
(2007)
Nature
, vol.445
, Issue.7130
, pp. 936-940
-
-
Zheng, Y.1
Josefowicz, S.Z.2
Kas, A.3
-
17
-
-
61949264338
-
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis
-
Shalev I, Wong KM, Foerster K, et al. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology. 2009;49(2):387-397.
-
(2009)
Hepatology
, vol.49
, Issue.2
, pp. 387-397
-
-
Shalev, I.1
Wong, K.M.2
Foerster, K.3
-
18
-
-
84939181477
-
The duality of fgl2 - Secreted immune checkpoint regulator versus membrane-associated procoagulant: Therapeutic potential and implications
-
Hu J, Yan J, Rao G, et al. The duality of Fgl2 - secreted immune checkpoint regulator versus membrane-associated procoagulant: Therapeutic potential and implications. Int Rev Immunol. 2016;35(4):325-339.
-
(2016)
Int Rev Immunol.
, vol.35
, Issue.4
, pp. 325-339
-
-
Hu, J.1
Yan, J.2
Rao, G.3
-
19
-
-
0030807894
-
Fulminant hepatic failure in murine hepatitis virus strain 3 infection: Tissue-specific expression of a novel fgl2 prothrombinase
-
Ding JW, Ning Q, Liu MF, et al. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: Tissue-specific expression of a novel fgl2 prothrombinase. J Virol. 1997;71(12):9223-9230.
-
(1997)
J Virol.
, vol.71
, Issue.12
, pp. 9223-9230
-
-
Ding, J.W.1
Ning, Q.2
Liu, M.F.3
-
20
-
-
59849115004
-
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma
-
Su K, Chen F, Yan WM, et al. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol. 2008;14(39):5980-5989.
-
(2008)
World J Gastroenterol.
, vol.14
, Issue.39
, pp. 5980-5989
-
-
Su, K.1
Chen, F.2
Yan, W.M.3
-
21
-
-
84867100989
-
Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis
-
Liu Y, Xu L, Zeng Q, et al. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int. 2012;32(10):1585-1595.
-
(2012)
Liver Int.
, vol.32
, Issue.10
, pp. 1585-1595
-
-
Liu, Y.1
Xu, L.2
Zeng, Q.3
-
22
-
-
27544481941
-
A function for interleukin 2 in foxp3-expressing regulatory T cells
-
Fontenot JD, Rasmussen JP, Gavin MA, et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6(11):1142-1151.
-
(2005)
Nat Immunol.
, vol.6
, Issue.11
, pp. 1142-1151
-
-
Fontenot, J.D.1
Rasmussen, J.P.2
Gavin, M.A.3
-
23
-
-
34147112868
-
CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2, 3-dioxygenase
-
Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2, 3-dioxygenase. J Clin Invest. 2007;117(4):1096-1106.
-
(2007)
J Clin Invest.
, vol.117
, Issue.4
, pp. 1096-1106
-
-
Guillonneau, C.1
Hill, M.2
Hubert, F.X.3
-
24
-
-
84939440156
-
FGL2 as a multimodality regulator of tumormediated immune suppression and therapeutic target in gliomas
-
Yan J, Kong LY, Hu J, et al. FGL2 as a Multimodality regulator of tumormediated immune suppression and therapeutic target in gliomas. J Natl Cancer Inst. 2015;107(8):djv137.
-
(2015)
J Natl Cancer Inst.
, vol.107
, Issue.8
, pp. djv137
-
-
Yan, J.1
Kong, L.Y.2
Hu, J.3
-
25
-
-
84866002291
-
The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data
-
Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.
-
(2012)
Cancer Discov.
, vol.2
, Issue.5
, pp. 401-404
-
-
Cerami, E.1
Gao, J.2
Dogrusoz, U.3
-
26
-
-
84955561447
-
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
-
Ceccarelli M, Barthel FP, Malta TM, et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell. 2016;164(3):550-563.
-
(2016)
Cell
, vol.164
, Issue.3
, pp. 550-563
-
-
Ceccarelli, M.1
Barthel, F.P.2
Malta, T.M.3
-
27
-
-
73649123907
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
-
Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110.
-
(2010)
Cancer Cell.
, vol.17
, Issue.1
, pp. 98-110
-
-
Verhaak, R.G.1
Hoadley, K.A.2
Purdom, E.3
-
28
-
-
0032477721
-
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice
-
Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci U S A. 1998;95(3):1218-1223.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, Issue.3
, pp. 1218-1223
-
-
Holland, E.C.1
Varmus, H.E.2
-
29
-
-
84966687479
-
The 2016 world health organization classification of tumors of the central nervous system: A summary
-
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of tumors of the central nervous system: A summary. Acta Neuropathol. 2016;131(6):803-820.
-
(2016)
Acta Neuropathol.
, vol.131
, Issue.6
, pp. 803-820
-
-
Louis, D.N.1
Perry, A.2
Reifenberger, G.3
-
30
-
-
84926076998
-
Stem cell signature in glioblastoma: Therapeutic development for a moving target
-
Nakano I. Stem cell signature in glioblastoma: Therapeutic development for a moving target. J Neurosurg. 2015;122(2):324-330.
-
(2015)
J Neurosurg.
, vol.122
, Issue.2
, pp. 324-330
-
-
Nakano, I.1
-
31
-
-
85061265951
-
Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment
-
Wang Q, Hu B, Hu X, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2018;33(1):152.
-
(2018)
Cancer Cell.
, vol.33
, Issue.1
, pp. 152
-
-
Wang, Q.1
Hu, B.2
Hu, X.3
-
32
-
-
84883656941
-
Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma
-
Bhat KP, Balasubramaniyan V, Vaillant B, et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24(3):331-346.
-
(2013)
Cancer Cell.
, vol.24
, Issue.3
, pp. 331-346
-
-
Bhat, K.P.1
Balasubramaniyan, V.2
Vaillant, B.3
-
33
-
-
0034020459
-
Combined activation of ras and akt in neural progenitors induces glioblastoma formation in mice
-
Holland EC, Celestino J, Dai C, et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000; 25(1):55-57.
-
(2000)
Nat Genet.
, vol.25
, Issue.1
, pp. 55-57
-
-
Holland, E.C.1
Celestino, J.2
Dai, C.3
-
34
-
-
52649169692
-
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
-
Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, et al. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res. 2008;14(16):5166-5172.
-
(2008)
Clin Cancer Res.
, vol.14
, Issue.16
, pp. 5166-5172
-
-
Heimberger, A.B.1
Abou-Ghazal, M.2
Reina-Ortiz, C.3
-
35
-
-
34248172651
-
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo
-
Grauer OM, Nierkens S, Bennink E, et al. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer. 2007;121(1):95-105.
-
(2007)
Int J Cancer
, vol.121
, Issue.1
, pp. 95-105
-
-
Grauer, O.M.1
Nierkens, S.2
Bennink, E.3
-
36
-
-
34247271308
-
Maintenance of the foxp3-dependent developmental program in mature regulatory T cells requires continued expression of foxp3
-
Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007;8(3):277-284.
-
(2007)
Nat Immunol.
, vol.8
, Issue.3
, pp. 277-284
-
-
Williams, L.M.1
Rudensky, A.Y.2
-
37
-
-
0037446535
-
Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: Suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells
-
Chan CW, Kay LS, Khadaroo RG, et al. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: Suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol. 2003;170(8):4036-4044.
-
(2003)
J Immunol.
, vol.170
, Issue.8
, pp. 4036-4044
-
-
Chan, C.W.1
Kay, L.S.2
Khadaroo, R.G.3
-
38
-
-
84885411102
-
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE
-
Khattar R, Luft O, Yavorska N, et al. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE. PLoS One. 2013;8(10): e72309.
-
(2013)
PLoS One
, vol.8
, Issue.10
-
-
Khattar, R.1
Luft, O.2
Yavorska, N.3
-
39
-
-
84898681799
-
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory th1 and th17 cell responses
-
Joller N, Lozano E, Burkett PR, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014;40(4):569-581.
-
(2014)
Immunity
, vol.40
, Issue.4
, pp. 569-581
-
-
Joller, N.1
Lozano, E.2
Burkett, P.R.3
-
40
-
-
84931568993
-
The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development
-
Rabizadeh E, Cherny I, Lederfein D, et al. The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development. Thromb Res. 2015;136(1):118-124.
-
(2015)
Thromb Res.
, vol.136
, Issue.1
, pp. 118-124
-
-
Rabizadeh, E.1
Cherny, I.2
Lederfein, D.3
-
41
-
-
84905892901
-
Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma
-
Qin WZ, Li QL, Chen WF, et al. Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma. Med Oncol. 2014;31(9):181.
-
(2014)
Med Oncol.
, vol.31
, Issue.9
, pp. 181
-
-
Qin, W.Z.1
Li, Q.L.2
Chen, W.F.3
-
42
-
-
0036187615
-
The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies
-
Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol. 2002; 196(3):254-265.
-
(2002)
J Pathol.
, vol.196
, Issue.3
, pp. 254-265
-
-
Bingle, L.1
Brown, N.J.2
Lewis, C.E.3
-
43
-
-
50249144131
-
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
-
Komohara Y, Ohnishi K, Kuratsu J, et al. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol. 2008;216(1):15-24.
-
(2008)
J Pathol.
, vol.216
, Issue.1
, pp. 15-24
-
-
Komohara, Y.1
Ohnishi, K.2
Kuratsu, J.3
-
44
-
-
70350728931
-
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
-
Solinas G, Germano G, Mantovani A, et al. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 2009;86(5):1065-1073.
-
(2009)
J Leukoc Biol.
, vol.86
, Issue.5
, pp. 1065-1073
-
-
Solinas, G.1
Germano, G.2
Mantovani, A.3
-
45
-
-
33644820339
-
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
-
Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157-173.
-
(2006)
Cancer Cell.
, vol.9
, Issue.3
, pp. 157-173
-
-
Phillips, H.S.1
Kharbanda, S.2
Chen, R.3
-
46
-
-
84872281338
-
Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2
-
Liu H, Yang PS, Zhu T, et al. Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. Int J Biochem Cell Biol. 2013;45(2):408-418.
-
(2013)
Int J Biochem Cell Biol.
, vol.45
, Issue.2
, pp. 408-418
-
-
Liu, H.1
Yang, P.S.2
Zhu, T.3
-
47
-
-
77956265027
-
The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection
-
Foerster K, Helmy A, Zhu Y, et al. The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol. 2010;53(4):608-615.
-
(2010)
J Hepatol.
, vol.53
, Issue.4
, pp. 608-615
-
-
Foerster, K.1
Helmy, A.2
Zhu, Y.3
-
48
-
-
0038182553
-
Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha
-
Ning Q, Lakatoo S, Liu M, et al. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. J Biol Chem. 2003;278(18): 15541-15549.
-
(2003)
J Biol Chem.
, vol.278
, Issue.18
, pp. 15541-15549
-
-
Ning, Q.1
Lakatoo, S.2
Liu, M.3
-
49
-
-
33646888039
-
Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: The role of sp1/Sp3 and STAT1/PU.1 composite cis elements
-
Liu M, Mendicino M, Ning Q, et al. Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: The role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol. 2006;176(11):7028-7038.
-
(2006)
J Immunol.
, vol.176
, Issue.11
, pp. 7028-7038
-
-
Liu, M.1
Mendicino, M.2
Ning, Q.3
-
50
-
-
57749083495
-
Hepatitis B virus-induced hFGL2 transcription is dependent on c-ets-2 and MAPK signal pathway
-
Han M, Yan W, Guo W, et al. Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem. 2008;283(47): 32715-32729.
-
(2008)
J Biol Chem.
, vol.283
, Issue.47
, pp. 32715-32729
-
-
Han, M.1
Yan, W.2
Guo, W.3
|